Product How it works Pricing Blog FAQ About Contact
CAMP4 Therapeutics

CAMP4 Therapeutics (NASDAQ: CAMP) revenue

CAMP4 Therapeutics reported revenue of $3.5m for fiscal 2025, 436.5% more than in fiscal 2024 ($0.7m). Since fiscal 2023 its revenue has grown by 899.4%, an average growth of 216.1% a year.

CAMP4 Therapeutics has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 3 fiscal years on record.

Revenue, in millions of US dollars0.420230.720243.52025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$3.5m+436.5%−$52.6m−1,502.4%
2024$0.7m+86.3%−$53.1m−8,142.3%
2023$0.4m—−$51.9m−14,822.6%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

CAMP4 Therapeutics revenue compared with its sector

By revenue for its latest fiscal year, CAMP4 Therapeutics ranks 386th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; CAMP4 Therapeutics, 436.5%.

RankCompanyRevenueRevenue growth
384thCG Oncology$4.0m254.7%
385thCrispr Therapeutics AG$3.5m−90.6%
386thCAMP4 Therapeutics$3.5m436.5%
387thSurrozen$3.5m−67.4%
388thOnkure Therapeutics$3.4m70.9%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of CAMP4 Therapeutics

How much revenue did CAMP4 Therapeutics make in fiscal 2025?
CAMP4 Therapeutics reported revenue of $3.5m for fiscal 2025, compared with $0.7m in fiscal 2024.
How much has the revenue of CAMP4 Therapeutics grown?
Between fiscal 2023 and fiscal 2025 it went from $0.4m to $3.5m: 899.4% more, an average growth of 216.1% a year.
What was the best year for revenue at CAMP4 Therapeutics?
Of its last 3 fiscal years, fiscal 2025, with $3.5m.
Where does CAMP4 Therapeutics rank in its sector by revenue?
It ranks 386th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for CAMP4 Therapeutics come from?
From the annual report (Form 10-K) that CAMP4 Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that CAMP4 Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on CAMP4 Therapeutics: the CAMP4 Therapeutics page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.